Correction to: Gadoxetic acid‑enhanced MRI in primary sclerosing cholangitis: added value in assessing liver function and monitoring disease progression
Crossref DOI link: https://doi.org/10.1007/s00261-021-03155-z
Published Online: 2021-07-05
Published Print: 2021-11
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Elkilany, Aboelyazid http://orcid.org/0000-0002-4311-0520
Geisel, Dominik
Müller, Tobias
Fischer, Andreas
Denecke, Timm
Text and Data Mining valid from 2021-07-05
Version of Record valid from 2021-07-05
Article History
First Online: 5 July 2021